Ashli Kovalick
Nurse Practitioner · Belden, MSNPI 1912374174
Payments from drug & device makers
Across 284 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Novo Nordisk$644
- Boehringer Ingelheim$623
- Abbott$468
- Sanofi-aventis U.S. LLC$277
- Sequel Med Tech, LLC$248
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,715100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 82 | $1,270 |
| Novo Nordisk | 45 | $644 |
| Boehringer Ingelheim | 34 | $623 |
| Abbott | 21 | $468 |
| Sanofi-aventis U.S. LLC | 21 | $277 |
| Sequel Med Tech, LLC | 7 | $248 |
| Bayer | 12 | $177 |
| Corcept Therapeutics | 9 | $156 |
| Dexcom, Inc. | 10 | $141 |
| Xeris Pharmaceuticals, Inc. | 7 | $105 |
| Insulet Corporation | 4 | $96 |
| AbbVie | 5 | $84 |
| Esperion Therapeutics, Inc. | 5 | $74 |
| Merck | 5 | $73 |
| Medtronic | 3 | $69 |
| AstraZeneca | 4 | $55 |
| Amarin Pharma, Inc. | 3 | $54 |
| Tandem Diabetes Care, Inc. | 2 | $38 |
| Mannkind Corporation | 2 | $34 |
| Novartis | 1 | $14 |
| Amgen | 1 | $13 |
| Lifescan, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TWIIST$112
How this compares
$4,727 in reported general payments places this provider in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 172 | $282,074 |
| JardianceEmpagliflozin | 216 | $255,562 |
| TrulicityDulaglutide | 91 | $144,239 |
| MounjaroTirzepatide | 89 | $136,743 |
| Tresiba Flextouch U-100Insulin Degludec | 120 | $101,872 |
| FarxigaDapagliflozin Propanediol | 68 | $80,681 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $71,236 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 35 | $55,315 |
| Tresiba Flextouch U-200Insulin Degludec | 47 | $54,516 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 35 | $42,269 |
| JanuviaSitagliptin Phosphate | 47 | $42,145 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 58 | $33,777 |
| Novolog FlexpenInsulin Aspart | 77 | $31,893 |
| Humalog Kwikpen U-100Insulin Lispro | 90 | $31,117 |
| KerendiaFinerenone | 21 | $21,954 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $644 | $296,599215 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog | $1,270 | $294,977225 claims |
| Boehringer IngelheimJardiance, Synjardy | $623 | $270,799232 claims |
| AstraZenecaFarxiga | $55 | $80,68168 claims |
| MerckJanuvia, Janumet Xr | $73 | $48,90759 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus | $277 | $46,93451 claims |
| BayerKerendia | $177 | $21,95421 claims |
| AbbVieSynthroid | $84 | $9,647104 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Belden
- Christina TreppendahlRidgeland$673K
- Catherine WellsJackson$75K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
- Jennifer HollyJackson$16K
- Mariah CoxGulfport$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.